Jacobson Pharma Corporation Limited (2633.HK)
HKD 1.01
(0.0%)
HKD 1.01
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 592.2 Million HKD | -52.02% |
| 2022 | 1.23 Billion HKD | 69.18% |
| 2021 | 729.47 Million HKD | -18.24% |
| 2020 | 892.21 Million HKD | -12.1% |
| 2019 | 1.01 Billion HKD | 173.4% |
| 2018 | 371.24 Million HKD | 56149.55% |
| 2017 | 660 Thousand HKD | 76.94% |
| 2016 | 373 Thousand HKD | -28.54% |
| 2015 | 522 Thousand HKD | -39.79% |
| 2014 | 867 Thousand HKD | -86.74% |
| 2013 | 6.54 Million HKD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 Q2 | 450.91 Million HKD | 0.0% |
| 2023 FY | 592.2 Million HKD | -52.02% |
| 2023 Q4 | 592.2 Million HKD | 0.0% |
| 2022 Q4 | 1.23 Billion HKD | 0.0% |
| 2022 FY | 1.23 Billion HKD | 69.18% |
| 2022 Q2 | 1.42 Billion HKD | 0.0% |
| 2021 FY | 729.47 Million HKD | -18.24% |
| 2021 Q4 | 729.47 Million HKD | 0.0% |
| 2021 Q2 | 715.21 Million HKD | 0.0% |
| 2020 Q4 | 892.21 Million HKD | 0.0% |
| 2020 FY | 892.21 Million HKD | -12.1% |
| 2020 Q2 | 505.07 Million HKD | 0.0% |
| 2019 Q4 | 1.01 Billion HKD | 0.0% |
| 2019 FY | 1.01 Billion HKD | 173.4% |
| 2019 Q2 | 727.45 Million HKD | 0.0% |
| 2018 Q4 | 371.24 Million HKD | 0.0% |
| 2018 Q2 | 228.1 Million HKD | 0.0% |
| 2018 FY | 371.24 Million HKD | 56149.55% |
| 2017 Q2 | 298 Thousand HKD | 0.0% |
| 2017 FY | 660 Thousand HKD | 76.94% |
| 2017 Q4 | 660 Thousand HKD | 0.0% |
| 2016 Q2 | 448 Thousand HKD | 0.0% |
| 2016 FY | 373 Thousand HKD | -28.54% |
| 2016 Q4 | 373 Thousand HKD | 0.0% |
| 2015 FY | 522 Thousand HKD | -39.79% |
| 2015 Q4 | 522 Thousand HKD | 0.0% |
| 2014 FY | 867 Thousand HKD | -86.74% |
| 2014 Q4 | - HKD | 0.0% |
| 2013 FY | 6.54 Million HKD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 2.07 Million HKD | -28467.308% |
| Grand Pharmaceutical Group Limited | 990.02 Million HKD | 40.184% |
| Extrawell Pharmaceutical Holdings Limited | 117.12 Million HKD | -405.618% |
| Wai Yuen Tong Medicine Holdings Limited | 276.2 Million HKD | -114.41% |
| Qianhai Health Holdings Limited | - HKD | -Infinity% |
| Lee's Pharmaceutical Holdings Limited | 70.63 Million HKD | -738.383% |
| Essex Bio-Technology Limited | 36.05 Million HKD | -1542.412% |
| Tongfang Kontafarma Holdings Limited | 12.8 Million HKD | -4526.201% |
| PuraPharm Corporation Limited | 81.09 Million HKD | -630.273% |
| SSY Group Limited | 1.94 Billion HKD | 69.593% |
| JBM (Healthcare) Limited | 43.8 Million HKD | -1252.055% |
| China Resources Pharmaceutical Group Limited | 16.61 Billion HKD | 96.436% |